Cancer Communications
indexed by SCI
BMC

Letter to the Editor
Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer
Hideharu Kimura, Tomoyuki Araya, Taro Yoneda, Hiroki Shirasaki, Koji Kurokawa, Tamami Sakai, Hayato Koba, Yuichi Tambo, Shingo Nishikawa, Takashi Sone & Kazuo Kasahara
Respiratory Medicine, Kanazawa University Hospital, Takara-machi 13-1, Kanazawa, Ishikawa, 920-8641, Japan
[Abstract] N/A
Cancer Communications   Epub date: 11/21/2019   doi:10.1186/s40880-019-0423-3
[PDF Full-text]

[ Html full-text] (BioMed Central)

[ PubMed]

Cite this article

Hideharu Kimura, Tomoyuki Araya, Taro Yoneda, Hiroki Shirasaki, Koji Kurokawa, Tamami Sakai, Hayato Koba, Yuichi Tambo, Shingo Nishikawa, Takashi Sone & Kazuo Kasahara. Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer. Cancer Commun (Lond). 2019, 39:78. doi:10.1186/s40880-019-0423-3


Export citations

EndNote

CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China